CompletedNCT01264055
Cross-sectional Characterization of Idiopathic Bronchiectasis
Studying Rare infectious disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
- Principal Investigator
- Andrew J Lipton, M.D.National Heart, Lung, and Blood Institute (NHLBI)
- Enrollment
- 275 enrolled
- Eligibility
- 18-100 years · All sexes
- Timeline
- 2011
Study locations (6)
- Stanford Medical Center, Stanford, California, United States
- National Jewish Health, Denver, Colorado, United States
- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
- Washington University, St. Louis, St Louis, Missouri, United States
- University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States
- St. Michael's Hospital, Toronto, Canada
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01264055 on ClinicalTrials.govOther trials for Rare infectious disease
Additional recruiting or active studies for the same condition.